Similar companies
Did Calidi Biotherapeutics Beat Earnings?
Calidi Biotherapeutics (CLDI) reported Q2 '26 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Calidi Biotherapeutics’s job postings, web traffic, and employee business outlook. See the full CLDI stock analysis or the earnings calendar for upcoming reports.
Calidi Biotherapeutics Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.5M | — | — | — | — | — | — |
| Gross margin | — | -26.1% | — | — | — | — | — | — |
| Operating margin | — | -267.7% | — | — | — | — | — | — |
| Net income | -5.1M | -4.1M | -5M | -5.7M | -5.1M | -4.1M | -4.1M | -4.2M |
| Net margin | — | -272.4% | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
Calidi Biotherapeutics Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Calidi Biotherapeutics’s quarterly revenue moved from $0 to $0.
When Is Calidi Biotherapeutics’s Next Earnings Date?
Calidi Biotherapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the CLDI earnings calendar.
Frequently Asked Questions: Calidi Biotherapeutics Earnings
Calidi Biotherapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Calidi Biotherapeutics reported Q2 '26 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the CLDI AI Score.
